Glenmark Pharma
Subsidiary received approval from China’s drug regulator (NMPA) for Ryaltris, a nasal spray used to treat allergic rhinitis in adults and children.
Jash Engineering
Received consolidated orders worth ₹50 crore in October, taking its total order book to ₹890 crore as of November 1.
Waaree Renewable Technologies
Scope under a commercial order increased by ₹27.2 crore, taking the total order value to ₹1,018 crore.
Transrail
Clarified that neither the company nor its subsidiaries are included in the World Bank’s list of ineligible firms or individuals.
Cosmic CRF
Received an order worth ₹15 crore from Indian Railways.
Vikran Engineering
Secured a Letter of Award worth ₹1,642 crore from an SPV for project execution.
RDB Infra
Entered into a pact with NRG Renewable Resources for solar power projects valued at ₹277 crore.
Alkem Laboratories
Inspection at its Baddi manufacturing facility concluded with no critical or major observations; EU-GMP inspection conducted by German health authorities from Nov 4–10.
Vodafone Idea
To subscribe to a 26% stake in an SPV for operating a captive power plant; will invest ₹4.3 crore in tranches.
Swan Defence
Signed a Letter of Intent worth $220 million with Rederiet Stenersen for constructing chemical tankers.
IRB Infrastructure Developers
Reported a 9% YoY rise in gross toll collections to ₹682 crore as of October.
Godrej Consumer Products (GCPL)
Completed acquisition of the FMCG business of Triology Solutions Pvt. Ltd.
Syrma SGS Technology
Entered an agreement to acquire a 60% stake in Elcome Integrated Systems Pvt. Ltd., marking its strategic entry into defence and maritime electronics.
BPCL
Consortium partners in Mozambique LNG Project resolved Force Majeure following improved security in the region.
Oil India
Lifted the Force Majeure declaration on Mozambique’s Offshore Rovuma Basin Block due to better security conditions.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.